Andrew Hopkins
Directeur Général chez Kinetic Discovery Ltd.
Fortune : 101 M $ au 31/05/2024
Postes actifs de Andrew Hopkins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Kinetic Discovery Ltd.
 Kinetic Discovery Ltd. Pharmaceuticals: MajorHealth Technology Kinetic Discovery Ltd. engages in the provision of drug discovery services. It offers full kinetic characterization, compound screening, fragment based screening, membrane protein analysis, active concentration determination, epitope mapping, promiscuous binding identification, and consultancy and assay development. The company was founded by Iva Navratilova and Andrew L. Hopkins and is headquartered in Dundee, the United Kingdom. | Directeur Général | - | - |
| Fondateur | - | - | |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 01/07/2012 | - |
| Directeur Général | 01/07/2012 | - | |
| Fondateur | 01/07/2012 | - |
Historique de carrière de Andrew Hopkins
Anciens postes connus de Andrew Hopkins
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EXSCIENTIA PLC | Directeur/Membre du Conseil | 01/01/2012 | 13/02/2024 |
| Directeur Général | 01/01/2012 | 13/02/2024 | |
| Fondateur | 01/01/2012 | 13/02/2024 | |
| University Of Dundee | Corporate Officer/Principal | 01/01/2007 | 01/01/2020 |
| Scottish Universities Life Sciences Alliance | Directeur/Membre du Conseil | 01/01/2011 | 01/01/2016 |
| Corporate Officer/Principal | 01/01/2007 | 01/01/2011 |
Formation de Andrew Hopkins
| The University of Manchester | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
| University Of Dundee | Doctorate Degree |
Statistiques
Internationale
| Royaume-Uni | 7 |
| Israël | 2 |
Opérationnelle
| Chief Executive Officer | 3 |
| Founder | 3 |
| Director/Board Member | 3 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXSCIENTIA PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Kinetic Discovery Ltd.
Kinetic Discovery Ltd. Pharmaceuticals: MajorHealth Technology Kinetic Discovery Ltd. engages in the provision of drug discovery services. It offers full kinetic characterization, compound screening, fragment based screening, membrane protein analysis, active concentration determination, epitope mapping, promiscuous binding identification, and consultancy and assay development. The company was founded by Iva Navratilova and Andrew L. Hopkins and is headquartered in Dundee, the United Kingdom. | Health Technology |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
| Scottish Universities Life Sciences Alliance |
- Bourse
- Insiders
- Andrew Hopkins
- Expérience
